Anna Shao

Ms. Anna Shao

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
WWWenxi Wang
Wenxi Wang
ASAnna Shao
Anna Shao
SFShisen Feng
Shisen Feng
MDMin Ding
Min Ding
GLGan Luo
Gan Luo

1 February 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
GLGan Luo
Gan Luo
QYQingliang Yang
Qingliang Yang
BYBingpeng Yao
Bingpeng Yao
YTYangfan Tian
Yangfan Tian
RHRuixia Hou
Ruixia Hou
WWWenxi Wang
Wenxi Wang
Slp forms a crystalline array of proteins on the outermost envelope of bacteria and archaea with a molecular weight of 40–200 kDa. Slp can self-assemble on the surface of liposomes in a proper environment via electrostatic interactions, which could be employed to functionalize liposomes by forming Slp-coated liposomes for various applications. Among the molecular characteristics, the stability, adhesion, and immobilization of biomacromolecules are regarded as the most meaningful. Compared to plain liposomes, Slp-coated liposomes show excellent physicochemical and biological stabilities. Recently, Slp-coated liposomes were shown to specifically adhere to the gastrointestinal tract, which was attributed to the “ligand–receptor interaction” effect. Furthermore, Slp as a “bridge” can immobilize functional biomacromolecules on the surface of liposomes via protein fusion technology or intermolecular forces, endowing liposomes with beneficial functions. In view of these favorable features, Slp-coated liposomes are highly likely to be an ideal platform for drug delivery and biomedical uses. This review aims to provide a general framework for the structure and characteristics of Slp and the interactions between Slp and liposomes, to highlight the unique properties and drug delivery as well as the biomedical applications of the Slp-coated liposomes, and to discuss the ongoing challenges and perspectives.

22 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WWWenxi Wang
Wenxi Wang
ASAnna Shao
Anna Shao
NZNan Zhang
Nan Zhang
JFJinzhang Fang
Jinzhang Fang
JRJennifer Jin Ruan
Jennifer Jin Ruan
BRBenfang Helen Ruan
Benfang Helen Ruan
Liposome (LP) encapsulation of doxorubicin (DOX) is a clinically validated method for cancer drug delivery, but its cellular uptake is actually lower than the free DOX. Therefore, we modified DOX-LP with a cationic polymer (Eudragit RL100; ER) to improve its cellular uptake and antitumor activity. The resulting DOX-ERLP was a 190 nm nanoparticle that was absorbed efficiently and caused cancer cell death in 5 hrs. Growth as measured by the MTT assay or microscopic imaging demonstrated that DOX-ERLP has at least a two-fold greater potency than the free DOX in inhibiting the growth of a DOX resistant (MCF7/adr) cell and an aggressive liver cancer H22 cell. Further, its in vivo efficacy was tested in H22-bearing mice, where four injections of DOX-ERLP reduced the tumor growth by more than 60% and caused an average of 60% tumor necrosis, which was significantly better than the DOX and DOX-LP treated groups. Our work represents the first use of polymethacrylate derivatives for DOX liposomal delivery, demonstrating the great potential of cationic polymethacrylate modified liposomes for improving cancer drug delivery.